For centuries, medicine has advanced because physicians discovered diseases that others failed to recognize. Every major breakthrough, from identifying infectious diseases to recognizing new cancers and genetic disorders, has depended on the remarkable ability of physicians and scientists to observe patterns, ask questions, and connect seemingly unrelated findings into new knowledge. We have long assumed that the limits of medicine were largely defined by the limits of human perception. A groundbreaking study published recently in Nature suggests that assumption may no longer be true.
Thus far our discussions have focused on whether AI would replace physicians by automating documentation, answering patient messages, interpreting imaging studies more efficiently, or reducing administrative work. Those are important applications, but they miss the larger transformation that is beginning to emerge.
Researchers at the University of California, Berkeley and collaborating institutions trained a deep learning model using more than 440,000 electrocardiograms linked to national death records in Sweden. Their objective was to identify patients at risk for sudden cardiac death, one of the leading causes of mortality worldwide. The model discovered a previously unrecognized biomarker hidden within a routine ECG that identified patients at exceptionally high risk for sudden cardiac death. Remarkably, many of these patients would not have been identified using current clinical guidelines, despite decades of research devoted to understanding electrocardiography.
The significance of this discovery extends well beyond cardiology. Cardiologists have interpreted millions of ECGs over the past several decades. Electrophysiologists have devoted entire careers to studying every electrical waveform produced by the human heart. The information was always present within the ECG, yet the mathematical relationships that predicted sudden cardiac death remained invisible to generations of highly trained physicians. Artificial intelligence did not simply recognize a known pattern more efficiently than a cardiologist. It identified a new biomarker that physicians themselves did not know existed.
READ: Sreedhar Potarazu | How do our kids prepare for the age of AI? (July 1, 2026)
Radiology is beginning to tell a similar story. Recent research has shown that AI systems can detect subtle bone metastases on CT scans with accuracy comparable to or exceeding experienced radiologists while also improving radiologists’ performance when the technology is used as an assistive tool.
Some observers view these developments as evidence that artificial intelligence will eventually replace physicians. I believe they point toward a very different conclusion. The future of medicine will not be defined by a competition between doctors and machines but by a division of intelligence in which each contributes something fundamentally different.
Artificial intelligence excels at quantitative intelligence. It can process enormous datasets, discover previously unknown biomarkers, identify subtle imaging abnormalities, recognize complex statistical relationships, and estimate risk with extraordinary precision. These are computational problems, and machines are becoming increasingly capable of solving them. Patients, however, do not experience illness as a collection of numbers, probabilities, or imaging findings. They experience illness through fear, uncertainty, family responsibilities, financial concerns, cultural beliefs, and deeply personal definitions of hope and quality of life.
This distinction highlights one of the most important differences between disease and illness. Disease is often measurable. Illness is experienced. Disease exists in laboratory values, imaging studies, ECG waveforms, pathology slides, and physiological measurements. Illness exists in conversations between physicians and families, in the anxiety surrounding a new diagnosis, in the difficult decisions about whether to pursue aggressive treatment, and in the personal values that shape every medical decision. Artificial intelligence may calculate the probability that a patient will experience sudden cardiac death, but it cannot determine whether that patient should undergo an invasive procedure, how much risk they are willing to accept, or what tradeoffs they consider meaningful in the context of their own life.
READ: Sreedhar Potarazu | Medicare’s new GLP-1 Bridge Program is a good start, but not a long term solution (June 30, 2026)
The physician’s role therefore becomes even more important as artificial intelligence becomes more capable. Rather than spending increasing amounts of time searching for disease hidden within complex data, physicians will increasingly interpret what those discoveries mean for individual patients. AI will contribute extraordinary quantitative intelligence, while physicians will contribute qualitative intelligence through empathy, ethical reasoning, contextual understanding, communication, and shared decision making.
The emergence of AI as a scientific discovery tool also raises an uncomfortable question for medical education. If machines are becoming better at discovering hidden disease signals than physicians, are we training doctors for the medicine of yesterday rather than the medicine of tomorrow? Future physicians will need more than anatomy, physiology, and clinical reasoning. They will need sufficient fluency in artificial intelligence to understand how these models reach their conclusions, when they can be trusted, when they should be questioned, and how to explain AI-assisted decisions to patients.
Perhaps that is the real lesson from these remarkable studies. Artificial intelligence is not replacing physicians because it has learned to think like doctors. It is transforming medicine because it can perceive aspects of human biology that physicians cannot. The future of healthcare will therefore depend not on choosing between doctors and artificial intelligence, but on combining the quantitative intelligence of machines with the qualitative intelligence of physicians. If we succeed, the result will not be medicine practiced by humans or by machines. It will be a new model of medicine that is more accurate, more personalized, and ultimately more human than either could achieve alone.